Loading…

Protocol - Tobacco Brand and Variety - Cigarettes

Add to My Toolkit
Description

Four questions used to determine the type of cigarette brand that is most often used by the respondent.

Specific Instructions

Although the National Survey on Drug Use and Health (NSDUH) only asks about Marlboro in Q3, the PhenX Working Group (WG) feels other brands could be asked about as well. The CEP feels the question could be asked without brand.

While the source instrument was developed to be administered by computer, the WG acknowledges these questions can be administered in a noncomputerized format.

The Content Expert Panel suggests investigators consider nicotine as derived from any source, including both natural and synthetic, when administering this protocol.

The Content Expert Panel recommends investigators substitute people-first language (i.e. replace behavior-based labels such as “smoker” with “people who smoke”) as outlined in Hefler, M. et al 2023, which may differ from the original protocol text.

Availability

Available

Protocol

1. What brand of cigarettes do you usually smoke?

    1 [ ] 1839 
    2 [ ] 305’s
    3 [ ] Alpine 
    4 [ ] American Spirit
    5 [ ] Basic
    6 [ ] Carlton
    7 [ ] Camel
    8 [ ] Capri
    9 [ ] Carlton
    10 [ ] Carnival 
    11 [ ] Cheyenne 
    12 [ ] Decade
    13 [ ] Djarum
    14 [ ] Doral
    15 [ ] Dunhill
    16 [ ] Eve
    17 [ ] Exeter
    18 [ ] Fortuna 
    19 [ ] GPC
    20 [ ] Grand Prix
    21 [ ] Kent
    22 [ ] Kentucky’s Best
    23 [ ] King Mountain
    24 [ ] Kool 
    25 [ ] L&M
    26 [ ] Liggett Select
    27 [ ] Lucky Strike
    28 [ ] Marlboro
    29 [ ] Maverick
    30 [ ] Merit
    31 [ ] Misty
    32 [ ] Monarch
    33 [ ] Montclair
    34 [ ] More
    35 [ ] Mustang
    36 [ ] Nat Sherman
    37 [ ] Native
    38 [ ] Newport
    39 [ ] Old Gold
    40 [ ] Palermo
    41 [ ] Pall Mall
    42 [ ] Parliament
    43 [ ] Players
    44 [ ] Pyramid
    45 [ ] Salem
    46 [ ] Saratoga
    47 [ ] Seneca
    48 [ ] Shield
    49 [ ] Signal
    50 [ ] Sonoma
    51 [ ] Tahoe
    52 [ ] Tareyton
    53 [ ] Tourney
    54 [ ] USA Gold
    55 [ ] Virginia Slims
    56 [ ] Wave
    57 [ ] Wildhorse
    58 [ ] Winston
    59 [ ] Vuse
    60 [ ] Remington
    61 [ ] Smoker’s Choice
    62 [ ] Some other brand

2. Were the cigarettes you smoked during the past 30 days menthol?

    1 [ ] Yes
    2 [ ] No  
       [ ] Don’t Know/Refused

3. IF (Q1=28] What length were the Marlboro cigarettes you smoked most often during the past 30 days? Were they shorts, regulars (also known as king-sized), or 100s?

    1 [ ] Shorts
    2 [ ] Regulars or king-sized
    3 [ ] 100s

4. During the past 30 days, that is, since [DATEFILL], have you smoked part or all of a roll-your-own tobacco cigarette?

    1 [ ] Yes
    2 [ ] No  
       [ ] Don’t Know/Refused
Personnel and Training Required

None

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Self-administered questionnaire

Lifestage

Child, Adolescent, Adult

Participants

Adolescents and adults (12+)

Selection Rationale

The protocol from the 2021 National Survey on Drug Use and Health (NSDUH) and PATH Study Wave 7 were selected because these surveys give a comprehensive assessment of tobacco use among the civilian, noninstitutionalized population of the United States. NSDUH was initiated in 1971, and it is currently conducted on an annual basis. NSDUH is a survey that includes substance use and is administered to individuals aged 12 and older.

The PATH Study is a nationally representative, in-person longitudinal cohort study of non-users and users of tobacco products and those at risk for tobacco use across the United States. Respondents 12 years old and up are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the U.S. Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.

Language

English, Other languages available at source

Standards
StandardNameIDSource
Derived Variables

None

Process and Review

The Tobacco Regulatory Research (TRR) Content Expert Panel (CEP) reviewed the measures in the Tobacco Regulatory Research collection in February 2024.   

Guidance from the TRR CEP includes:

•    Updated protocol

Previous version in Toolkit archive (link)

Protocol Name from Source

National Survey on Drug Use and Health (NSDUH), 2021, Population Assessment of Tobacco and Health (PATH) Study Wave 7

Source

Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2020). 2021 National Survey on Drug Use and Health (NSDUH): Draft Web Specifications for Programming (English Version). Substance Abuse and Mental Health Services Administration, Rockville, MD. Questions CG11, CG11a, CG12, CGMENTH1, CGLNTH, CG14.

National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. [https://www.icpsr.umich.edu/files/NAHDAP/pathstudy/Final%20PATH%20Wave%207%20English%20Adult%20Questionnaire.pdf]

General References

Hefler, M., Durkin, S.J., Cohen, J.E., Henriksen, L., OConnor, R., Barnoya, J., Hill, S.E. and Malone, R.E., 2023. New policy of people-first language to replace ‘smoker’, ‘vaper’, ‘ tobacco user’ and other behaviour-based labels. Tobacco control, 32(2), pp.133-134.

Sharma, A., Fix, B. V., Delnevo, C., Cummings, K. M., & OConnor, R. J. (2016). Trends in market share of leading cigarette brands in the USA: national survey on drug use and health 2002–2013. BMJ open, 6(1).

Budenz A, Grana R. Cigarette Brand Use and Sexual Orientation: Intersections With Gender and Race or Ethnicity. (2021). Prev Chronic Dis, 18: E94. doi: 10.5888/pcd18.210160.

Protocol ID

730708

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Brand
PX730708010000 What brand of cigarettes do you usually smoke? N/A
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Marlboro
PX730708030000 What length were the Marlboro cigarettes you more
smoked most often during the past 30 days? Were they shorts, regulars (also known as king-sized), or 100s? show less
N/A
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Menthol
PX730708020000 Were the cigarettes you smoked during the more
past 30 days menthol? show less
N/A
PX730708_Tobacco_Brand_And_Variety_Cigarettes_Own_Rolled
PX730708040000 During the past 30 days, that is, since more
[DATEFILL], have you smoked part or all of a roll-your-own tobacco cigarette? show less
N/A
Tobacco Regulatory Research: Agent
Measure Name

Tobacco Brand and Variety

Release Date

October 31, 2024

Definition

This measure consists of questions used to determine the tobacco product brand and type used by the respondent most often.

Purpose

This measure is used to assess the type and brand of tobacco product used by respondents.

Keywords

Tobacco Regulatory Research, TRR, cigar brand, cigar, cigar type, cigar variety, tobacco brand, tobacco variety, little cigars, cigarillos, TUS-CPS, agent, brand, tobacco type, tobacco product, Cigarette smoking, menthol, cigarettes, regulars, smokeless tobacco, snus, moist snuff, dip tobacco, split tobacco, Chewing Tobacco, flavors, Population Assessment of Tobacco and Health, PATH, smokeless, dip, Snuff, spit

Measure Protocols
Protocol ID Protocol Name
730704 Tobacco Brand and Variety - Smokeless Tobacco
730707 Tobacco Brand and Variety - Cigars
730708 Tobacco Brand and Variety - Cigarettes
Publications

There are no publications listed for this protocol.